Flynn James E

Average Profitability
<0.0001%
Insider Buys Quantity
69
Insider Buys Sum
$592.93M
Insider Sells Quantity
82
Insider Sells Sum
$219.44M

Insider Activity of Flynn James E

According to the SEC Form 4 filings, Flynn James E, being in a position of

  1. *Possible Member of 10% Group at AdaptHealth Corp.,
    оver the last 12 months, has bought 0 shares, and sold 350000 shares for $3.82M,
    over all time since 2024-03-08, has bought 0 shares, and sold 350000 shares for $3.82M.

The largest purchase of all time was on 2014-08-05 and amounted to 2668934 shares of Adverum Biotechnologies, Inc. for $63.85M.

The largest sale of all time was on 2024-10-22 and amounted to 1000000 shares of Nuvalent, Inc. for $97.75M.

Biography of Flynn James E

No biography is available at this moment.

2024-10-22SaleNuvalent, Inc.
NUVL
* Director by deputization
1M
1.3662%
$97.75$97.75M0%
2024-09-17PurchaseBicara Therapeutics Inc. Common Stock
BCAX
Possible Members of 10% Group
35,000
0.045%
$18.00$630,000-12.49%
2024-03-12SaleAdaptHealth Corp.
AHCO
*Possible Member of 10% Group
114,906
0.0832%
$10.70$1.23M-3.51%
2024-03-11SaleAdaptHealth Corp.
AHCO
*Possible Member of 10% Group
182,607
0.1361%
$11.02$2.01M-3.59%
2024-03-08SaleAdaptHealth Corp.
AHCO
*Possible Member of 10% Group
52,487
0.0387%
$10.93$573,652-3.5%
2024-02-16PurchaseLarimar Therapeutics, Inc.
LRMR
* Director by Deputization
4.29M
6.6831%
$8.74$37.5M-39.44%
2022-11-03PurchaseNuvalent, Inc.
NUVL
director
650,000
1.388%
$33.50$21.77M+32.21%
2022-11-03PurchaseNuvalent, Inc.
NUVL
director
1.3M
2.776%
$33.50$43.55M+32.21%
2022-09-16PurchaseLarimar Therapeutics, Inc.
LRMR
11.11M
49.2054%
$3.15$35M+21.88%
2021-10-26PurchaseXilio Therapeutics, Inc.
XLO
10 percent owner
387,500
1.4134%
$16.00$6.2M-76.08%
2021-08-02PurchaseNuvalent, Inc.
NUVL
600,000
0.7259%
$8.50$5.1M-23.21%
2021-07-09SaleMirum Pharmaceuticals, Inc.
MIRM
10 percent owner
198,650
0.6325%
$15.81$3.14M+11.25%
2021-07-07SaleMirum Pharmaceuticals, Inc.
MIRM
10 percent owner
13,674
0.045%
$15.87$216,993+14.33%
2021-07-06SaleMirum Pharmaceuticals, Inc.
MIRM
10 percent owner
98,478
0.322%
$16.20$1.59M+11.07%
2021-07-02SaleMirum Pharmaceuticals, Inc.
MIRM
10 percent owner
21,198
0.0709%
$17.01$360,599+7.82%
2021-06-30PurchaseLarimar Therapeutics, Inc.
LRMR
685,710
3.341%
$8.75$6M-2.39%
2021-06-01PurchaseSingular Genomics Systems, Inc.
OMIC
10 percent owner
1.5M
3.3473%
$22.00$33M-62.91%
2021-05-04PurchaseWerewolf Therapeutics, Inc.
HOWL
10 percent owner
800,000
4.4986%
$16.00$12.8M-12.48%
2021-03-30PurchaseEdgewise Therapeutics, Inc.
EWTX
10 percent owner
1.25M
1.3005%
$16.00$20M-42.5%
2021-02-09PurchaseTerns Pharmaceuticals, Inc.
TERN
10 percent owner
665,000
3.5834%
$17.00$11.3M-48.44%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.